Audrey Le Formal

MET Is a Potential Target across All Papillary Renal Cell Carcinomas: Result from a Large Molecular Study of pRCC with CGH Array and Matching Gene Expression Array

Laurence Albigès, Justine Guégan, Audrey Le Formal et al. · Clinical Cancer Research · 2014 · 175 citations

Medicine, Molecular Genetics, Oncology +17

Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC)

Soizick Mesnage, Aurélie Auguste, Catherine Genestie et al. · Annals of Oncology · 2016 · 173 citations · Full text

Medicine, Immunology, Oncology +17

Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis

Aurélie Auguste, Félix Blanc‐Durand, Marc Deloger et al. · Cells · 2020 · 64 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiative

Aurélie Auguste, Catherine Genestie, Marco de Bruyn et al. · Modern Pathology · 2018 · 60 citations · Full text

Medicine, Gynecology, Oncology +14

Changes in DNA Damage Response Markers with Treatment in Advanced Ovarian Cancer

Paul Kubelac, Catherine Genestie, Aurélie Auguste et al. · Cancers · 2020 · 52 citations · Full text

Medicine, Molecular Biology, Oncology +17